U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag
Natco Pharma’s finished dosage formulations manufacturing unit in Visakhapatnam has received U.S. Food and Drug Administration’s establishment inspection report with a voluntary action indicated (VAI) classification. The U.S. FDA had conducted an inspection of the facility in Parawada, Visakhapatnam, from August 17-21 and issued Form-483 with four observations. “We hereby notify the company has received…
Read More “U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag” »
